BARDA awards Elusys $40.6 million

Elusys Therapeutics Inc. (Pine Brook, N.J.) said HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded the company a second contract year of funding valued at $40.6 million to develop Anthim to prevent and treat anthrax infection. Elusys has already received $16.8 million under the five-year contract, which has the potential to be worth up to $143 million. ...